INTERFERON THERAPY FOR PH(1)-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA PATIENTS RELAPSING AFTER T-CELL DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION